Thymocartin (acetate)
Thymocartin (TP 4) acetate is the 32-35 fragment of thymic factor (thymopoietin) . Thymocartin acetate inhibits apoptosis of peripheral blood lymphocytes in HIV infected individuals. Thymocartin acetate is potential for immunodeficiency diseases research[1][2].
Product Specifications
CAS Number
85503-03-3
Product Name Alternative
Thymopoietin II (32-35) (acetate) ; TP 4 (acetate)
UNSPSC
12352211
Target
Apoptosis
Type
Reference compound
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/thymocartin-acetate.html
Smiles
CC(O)=O.CC(C)[C@@H](C(O)=O)NC([C@H](CC(O)=O)NC([C@H](CCCCN)NC([C@@H](N)CCCNC(N)=N)=O)=O)=O
Molecular Formula
C23H44N8O9
Molecular Weight
576.64
References & Citations
[1]Lang S, et al. Transport and metabolic pathway of thymocartin (TP4) in excised bovine nasal mucosa. J Pharm Pharmacol. 1996 Nov;48 (11) :1190-6. |[2]la Szende B, et al., Reduction of apoptosis of in vitro cultured peripheral blood lymphocytes of HIV positive individuals by thymocartin[J]. Medical Science Monitor, 1997, 3 (4) : BR456-BR459.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
